| Rank | Bedrijf | |
|---|---|---|
| 1 | MSD | |
| 2 | SABIC | |
| 3 | Bayer | |
| 4 | BASF | |
| 5 | Abbott | |
| 6 | Johnson & Johnson Innovative Medicine | |
| 7 | AkzoNobel | |
| 8 | Dow Benelux | |
| 9 | GlaxoSmithKline (GSK) | |
| 10 | Novartis | |
| Strategie | Score | |
| 1 | MSD | |
| 2 | SABIC | |
| 3 | Bayer | |
| 4 | BASF | |
| 5 | Johnson & Johnson Innovative Medicine | |
| 6 | Abbott | |
| 7 | AkzoNobel | |
| 8 | Dow Benelux | |
| 9 | GlaxoSmithKline (GSK) | |
| 10 | Novartis | |
| Klant | Score | |
| 1 | SABIC | |
| 2 | Bayer | |
| 3 | MSD | |
| 4 | BASF | |
| 5 | Abbott | |
| 6 | AkzoNobel | |
| 7 | Johnson & Johnson Innovative Medicine | |
| 8 | Novartis | |
| 9 | GlaxoSmithKline (GSK) | |
| 10 | Dow Benelux | |
| Technologie | Score | |
| 1 | MSD | |
| 2 | Bayer | |
| 3 | Abbott | |
| 4 | SABIC | |
| 5 | Johnson & Johnson Innovative Medicine | |
| 6 | BASF | |
| 7 | AkzoNobel | |
| 8 | GlaxoSmithKline (GSK) | |
| 9 | Dow Benelux | |
| 10 | Novartis | |
| Organisatie | Score | |
| 1 | SABIC | |
| 2 | Bayer | |
| 3 | BASF | |
| 4 | Johnson & Johnson Innovative Medicine | |
| 5 | Abbott | |
| 6 | AkzoNobel | |
| 7 | MSD | |
| 8 | Dow Benelux | |
| 9 | Novartis | |
| 10 | GlaxoSmithKline (GSK) | |